author-photo

Constance M. Yuan

33

Papers

273

Citations

Citation Trend

Filter By

Papers (19) Sort By

Journal Conference Others

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study.

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (15)
Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
Disease detection methodologies in relapsed B‐cell acute lymphoblastic leukemia: Opportunities for improvement

2020 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Deep and Durable Remissions of Relapsed Multiple Myeloma on a First-in-Humans Clinical Trial of T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain

2020 Blood
Show All
- Source
- Cite
- Save
Citations (6)
Phase I Study of Lenalidomide Combined with Dose-Adjusted EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma in Participants with or without HIV (NCT02911142)

2020 Blood
Show All
- Source
- Cite
- Save
Citations (10)
Risk-Adapted, Ofatumumab-Based Chemoimmunotherapy and Maintenance in Treatment-Naïve CLL: A Phase II Study

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1440: Evolution of CD19 expression in pediatric B-cell malignancies in the era of targeted therapy

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-146: Phase I CD22 CAR T-cell trial updates

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (4)